{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:34Z","timestamp":1791078874282,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T00:00:00Z","timestamp":1212105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>CD8+ cutaneous T\u2010cell lymphoma (CTCL) is a relatively rare subset of the non\u2010Hodgkins lymphomas. Bexarotene has been FDA\u2010approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL. Herein, we report on a patient whose CD8+ CTCL completely responded to treatment with bexarotene. Am. J. Hematol., 2008. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.21231","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T15:46:16Z","timestamp":1212162376000},"page":"744-746","source":"Crossref","is-referenced-by-count":6,"title":["CD8+ cutaneous T\u2010cell lymphoma successfully treated with bexarotene: A case report and review of the literature"],"prefix":"10.1002","volume":"83","author":[{"given":"Srivalli","family":"Gopaluni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiza","family":"Perzova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Shrimpton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Poiesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00494.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032810"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65144-9"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003303421304"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120016422"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-30"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0501734102"},{"key":"e_1_2_1_10_2","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T\u2010cell lymphoma cells: Relevance to mechanism of therapeutic action","volume":"8","author":"Zhang C","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200101)66:1<32::AID-AJH1004>3.0.CO;2-3"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.2.199"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1309\/NNV4L5G5A0KF1T06"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2002.290804.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03888.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.127.7.1020"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90132-H"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70201-4"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70007-1"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199012000-00012"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70074-R"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archderm.1990.01670300101017","article-title":"CD8+ cutaneous T\u2010cell lymphoma with pagetoid epidermotropism and angiocentric and angiodestructive infiltration","volume":"126","author":"Fujiwara Y","year":"1990","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087025"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000054652"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03888.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199506000-00012"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)00065-3"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.4.2.180"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.11.058"},{"key":"e_1_2_1_31_2","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early\u2010stage cutaneous T\u2010cell lymphoma","volume":"137","author":"Duvic M","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200409000-00002"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002800103500903"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01475-0"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/10428190290021425","article-title":"Response of CD30+ large cell lymphoma of the skin to bexarotene","volume":"43","author":"Keun YK","journal-title":"Leuk Lymphoma"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.02.055"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.12.018"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200115070-00002"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.06.044"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.21231","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.21231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T13:59:17Z","timestamp":1699970357000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.21231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1002\/ajh.21231"],"URL":"https:\/\/doi.org\/10.1002\/ajh.21231","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,9]]}}}